NuCana plc

NCNA

3 Followers
$0.10 -65.83% -$0.20
15 May
Upcoming Earnings
 
Market Cap.
 
P/E
Loading...

My Notes

Začít psát

Profile

NuCana is a biotechnology company focused on developing new cancer treatments. The company utilizes its proprietary ProTide technology to create more effective versions of existing chemotherapy drugs, aiming to enhance their efficacy while reducing side effects. NuCana focuses on improving treatment outcomes for patients with various types of cancer, including pancreatic, liver, and ovarian cancers.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade